脑病变手术中的增强现实可视化:导航显微神经外科中其潜力与当前局限的前瞻性随机对照评估
这项前瞻性随机对照研究纳入55个颅内病变,随机分为增强现实(AR)导航显微镜组(39例)和常规神经导航组(16例),评估术中可视化参数与临床影响。结果显示AR显示占切除时间的44.4%,导航视图(画中画)最为常用,66.7%的术者认为AR可视化有帮助,AR组导航指针使用次数显著减少(P<0.001),但43.6%的病例中重要解剖结构的视野被AR信息部分或完全遮挡。
要点
- AR显示占切除时间的44.4%,以导航视图(75.7%)和画中画模式(72.5%)为主。
- 43.6%的病例中重要解剖结构视野被AR信息部分或完全遮挡。
- AR组导航指针使用2.6次/切除小时 vs 常规导航组9.7次/切除小时,导航 effort 显著降低(P<0.001)。
核心结论
- 基于头戴式显示器(HUD)的AR可视化在脑肿瘤手术中的主要优势是整合的连续显示,允许无指针导航。
研究设计与样本
- 前瞻性随机对照研究,纳入55个颅内病变,随机分配至AR导航显微镜组(n=39)或常规神经导航组(n=16)。
主要发现
- AR显示用于44.4%的切除时间,主要AR类型为导航视图(75.7%),其次为目标体积(20.1%);主要AR模式为画中画(PiP)(72.5%),其次为叠加显示(23.3%)。
- 43.6%的病例中,重要解剖结构的视野被AR信息部分或完全遮挡。
- 7.7%的病例仅使用MRI导航,30.8%使用一个、23.1%使用两个、38.5%使用三个或更多对象分割进行AR导航。
- 66.7%的术者认为AR可视化在个体手术病例中有帮助;AR深度信息和准确性被评为可接受(中位数3.0 vs 常规神经导航中位数5.0)。
- 导航指针平均使用次数为2.6次/切除小时(AR组)vs 9.7次/切除小时(常规神经导航组),AR组导航 effort 显著降低(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Augmented reality (AR) has the potential to support complex neurosurgical interventions by including visual information seamlessly. This study examines intraoperative visualization parameters and clinical impact of AR in brain tumor surgery. METHODS: Fifty-five intracranial lesions, operated either with AR-navigated microscope (n = 39) or conventional neuronavigation (n = 16) after randomization, have been included prospectively. Surgical resection time, duration/type/mode of AR, displayed objects (n, type), pointer-based navigation checks (n), usability of control, quality indicators, and overall surgical usefulness of AR have been assessed. RESULTS: AR display has been used in 44.4% of resection time. Predominant AR type was navigation view (75.7%), followed by target volumes (20.1%). Predominant AR mode was picture-in-picture (PiP) (72.5%), followed by 23.3% overlay display. In 43.6% of cases, vision of important anatomical structures has been partially or entirely blocked by AR information. A total of 7.7% of cases used MRI navigation only, 30.8% used one, 23.1% used two, and 38.5% used three or more object segmentations in AR navigation. A total of 66.7% of surgeons found AR visualization helpful in the individual surgical case. AR depth information and accuracy have been rated acceptable (median 3.0 vs. median 5.0 in conventional neuronavigation). The mean utilization of the navigation pointer was 2.6 × /resection hour (AR) vs. 9.7 × /resection hour (neuronavigation); navigation effort was significantly reduced in AR (P < 0.001). CONCLUSIONS: The main benefit of HUD-based AR visualization in brain tumor surgery is the integrated continuous display allowing for pointer-less navigation. Navigation view (PiP) provides the highest usability while blocking the operative field less frequently. Visualization quality will benefit from improvements in registration accuracy and depth impression. GERMAN CLINICAL TRIALS REGISTRATION NUMBER: DRKS00016955.
引用
- Roethe AL, Rösler J, Misch M, et al. Augmented reality visualization in brain lesions: a prospective randomized controlled evaluation of its potential and current limitations in navigated microneurosurgery. Acta Neurochir (Wien). 2021. PMID: 34904183. doi:10.1007/s00701-021-05045-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。